Our Team in the News


BioPlan Associates' Ronald Rader

Ron Rader, Sr. Dir. Technical Research: named Editor-in-Chief of Biopharmaceuticals a new peer-reviewed journal from Landes Bioscience. Biopharmaceuticals is the first and only peer-reviewed journal about biopharmaceuticals. Biopharmaceuticals seeks submission of articles concerning biopharmaceuticals and the industry. Please contact the Editor-in-Chief if interested in submitting an article.


BioPlan Associates' Faiz Kermani PhD

Dr Faiz Kermani, Advisory Board: Has helped establish the "Global Health Education Foundation" (GHEF), a not-for-profit healthcare charity to improve educational resources and training for healthcare professionals in developing countries.
At least 1.3 billion people worldwide lack access to the most basic healthcare. The new non-profit foundation, Global Health Education Foundation, aims to tackle such issues. As President of GHEF, Dr Kermani is supporting the R&D focus of the charity to reduce health disparities among developing countries. In particular, the lack of appropriate educational resources and training opportunities for healthcare professionals. http://www.globalhef.org


BioPlan Associates' Managing Director Eric Langer

Eric Langer, Managing Partner: On Advisory Board of “BioProcess Asia Pacific Conference” July 2010 Singapore.
The Biopharmaceutical market in Asia pacific is growing at a rate among the highest in the globe. This is creating a strong need for production of biopharmaceuticals at higher qualities and volumes. Bioprocess AsiaPacific brings together global leaders within biopharmaceutical industry to explore dynamic strategies, benchmark technologies and analyze sustaining the growth of the industry. http://fleminggulf.com/conference/life-science/BioProcessAsiaPacific.


Publications

The only reference database concerning biopharmaceutical products!

View Product Search in the database

View Company Search in the database

Sample Monographs:

View Industry Reviews

Download Flier [PDF 373k]

Download Sample Synagis [PDF 260k]

Author: Ronald A. Rader
Publisher: BioPlan Associates, Inc.

SPECIAL! Order the database subscription and, while supplies last, receive the last print version of Biopharmaceuticals in the U.S. and European Markets!

Click the Order link below to email BioPlan Associates that you are interested in a subscription. We will contact you with subscription information.

Order Now

  • Content
  • Coverage
  • Online Edition
  • Companies involved, and relationships
  • Composition, biological and chemical aspects
  • Manufacturing methods
  • Patents and technology transfer
  • Regulatory history and status
  • Approved indications
  • Market size and share
  • Nomenclature
  • Controversial aspects, and more!
  • Recombinant and other proteins
  • Antibodies — monoclonal, radioimmune conjugates
  • Vaccines
  • Enzymes and toxins
  • Blood products — human and animal-derived
  • Cultured cell and tissue products
  • And other products, e.g., vaccine adjuvants, antisense drugs
  • Bigger! 1,602 pages and over 580 monographs and product entries
  • Better! Now includes European/EU products;
  • Indexes — 32,000+ index entries
  • Includes all US, and European products, and many biodefense and biogeneric products